COM:ENLIVEX
Enlivex Therapeutics
- Stock
Last Close
0.84
22/11 21:00
Market Cap
29.22M
Beta: -
Volume Today
221.59K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -7.02M - | -15.37M 118.81% | -16.02M 4.28% | -5.95M 62.89% | -4.24M 28.65% | -9.38M 121.22% | -11.82M 26.00% | -14.47M 22.36% | -31.06M 114.68% | -29.07M 6.41% | |
depreciation and amortization | 5K - | 17K 240% | 38K 123.53% | 64K 68.42% | 121K 89.06% | 206K 70.25% | 286K 38.83% | 546K 90.91% | 777K 42.31% | 835K 7.46% | |
deferred income tax | 119K - | -5.59M - | |||||||||
stock based compensation | 736K - | 2.62M 256.39% | 700K 73.31% | 408K 41.71% | 1.01M 147.30% | 810K 19.72% | 670K 17.28% | 2.91M 334.93% | 2.71M 6.93% | ||
change in working capital | 1.90M - | -506K 126.63% | -241K 52.37% | -886K 267.63% | 83K 109.37% | 1.04M 1,153.01% | -306K 129.42% | -1.36M 343.46% | 804K 159.25% | -1.82M 326.12% | |
accounts receivables | 567K - | 41K - | 1.82M 4,346.34% | -1.25M 168.51% | 278K 122.26% | 608K 118.71% | |||||
inventory | -790K - | -41K - | -1.82M 4,346.34% | 1.25M 168.51% | -278K 122.26% | ||||||
accounts payables | 2.15M - | 234K 89.11% | -712K 404.27% | -681K 4.35% | 145K 121.29% | 114K 21.38% | 36K 68.42% | 442K 1,127.78% | 1.17M 164.25% | -1.12M 195.98% | |
other working capital | -249K - | -740K 197.19% | 471K 163.65% | 18K 96.18% | -62K 444.44% | 926K 1,593.55% | -342K 136.93% | -1.80M 426.02% | -364K 79.77% | -1.30M 258.52% | |
other non cash items | -28K - | -18K 35.71% | 39K 316.67% | 7K 82.05% | -132K 1,985.71% | 168K 227.27% | 167K 0.60% | 413K 147.31% | 2.81M 581.36% | 6.53M 131.98% | |
net cash provided by operating activities | -4.41M - | -13.25M 200.50% | -15.49M 16.88% | -6.35M 58.98% | -3.16M 50.24% | -7.04M 122.75% | -11.01M 56.33% | -17.54M 59.37% | -23.95M 36.55% | -23.52M 1.80% | |
investments in property plant and equipment | -63K - | -48K 23.81% | -18K 62.50% | -2K 88.89% | -461K 22,950% | -193K 58.13% | -1.02M 427.98% | -1.63M 59.47% | -8.12M 399.82% | -236K 97.09% | |
acquisitions net | 1.55M - | -20.03M - | -9.71M 51.55% | 133K 101.37% | |||||||
purchases of investments | -40K - | -7.71M 19,185% | -19.96M 158.72% | -104.42M 423.18% | -1.61M 98.46% | -26.17M 1,527.24% | |||||
sales maturities of investments | -1.55M - | 67.63M - | 72.25M 6.83% | 301K 99.58% | |||||||
other investing activites | -22M - | 10M 145.45% | 9M 10% | 3.01M 66.57% | -32K 101.06% | 1.55M 4,937.50% | 20.03M - | 9.71M 51.55% | |||
net cash used for investing activites | -22.06M - | 9.95M 145.11% | 8.98M 9.75% | 3.01M 66.52% | -533K 117.73% | -6.36M 1,093.06% | -20.98M 229.88% | -38.41M 83.10% | 62.52M 262.79% | -25.97M 141.53% | |
debt repayment | |||||||||||
common stock issued | 6.09M - | 5.19M - | 7.71M 48.38% | 24.47M 217.46% | 53.17M 117.33% | 150K 99.72% | 360K 140% | ||||
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | 36.78M - | 36.78M 0% | 599K - | 8.62M 1,338.23% | 7.81M 9.37% | ||||||
net cash used provided by financing activities | 36.78M - | 36.78M 0% | 6.09M 83.45% | 5.19M - | 8.31M 59.92% | 33.08M 298.29% | 60.98M 84.34% | 150K 99.75% | 360K 140% | ||
effect of forex changes on cash | -36.78M - | -769K - | 826K 207.41% | 390K 52.78% | -408K 204.62% | 112K - | |||||
net change in cash | 10.31M - | -3.30M 131.97% | -415K 87.41% | -3.35M 706.02% | 731K 121.85% | -4.27M 683.86% | 1.49M 134.86% | 4.62M 210.75% | 38.72M 737.39% | -49.02M 226.60% | |
cash at beginning of period | 270K - | 10.58M 3,819.63% | 7.29M 31.15% | 6.87M 5.70% | 9.01M 31.06% | 9.79M 8.74% | 5.52M 43.59% | 7.01M 26.94% | 11.64M 65.94% | 49.95M 329.23% | |
cash at end of period | 10.58M - | 7.29M 31.15% | 6.87M 5.70% | 3.53M 48.68% | 9.74M 176.12% | 5.52M 43.26% | 7.01M 26.94% | 11.64M 65.94% | 50.36M 332.77% | 926K 98.16% | |
operating cash flow | -4.41M - | -13.25M 200.50% | -15.49M 16.88% | -6.35M 58.98% | -3.16M 50.24% | -7.04M 122.75% | -11.01M 56.33% | -17.54M 59.37% | -23.95M 36.55% | -23.52M 1.80% | |
capital expenditure | -63K - | -48K 23.81% | -18K 62.50% | -2K 88.89% | -461K 22,950% | -193K 58.13% | -1.02M 427.98% | -1.63M 59.47% | -8.12M 399.82% | -236K 97.09% | |
free cash flow | -4.47M - | -13.30M 197.34% | -15.50M 16.60% | -6.35M 59.02% | -3.62M 43.00% | -7.23M 99.72% | -12.03M 66.24% | -19.17M 59.38% | -32.08M 67.34% | -23.76M 25.93% |
All numbers in USD (except ratios and percentages)